Drawing for LABSAT

USPTO serial 79261179

LABSAT

Reviewed by CopyMark Law Group

Reg. 5893952Status 707Registered
Filing date
Status date
Registration date
Oct 29, 2019
Examiner
CAHILL, CLARE GALLAGHER
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with LABSAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Courtney Thompson

Courtney Thompson Fredrikson & Byron, P.A.60 South Sixth Street, Suite 1500Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005[ Diagnostic substances, preparations and agents for medical use; diagnostic reagents and contrast media for medical use; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical use; diagnostic test reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; biotechnological preparations for medical use for the treatment of cancer and metabolic diseases ]SECTION 71 - CANCELLED—
009Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms; optical apparatus and instruments, namely, microscopes, optical profilers, optical filters, optical glasses, optical lens sights, optical scanners, optical readers, optical reflectors; weighing apparatus and instruments, namely, scales and balances; measuring apparatus and instruments, namely, instruments for measuring the quantity of contaminants, pollutants, or malignant cells in animal, plant, or microorganism cells and tissues; signaling apparatus and instruments, namely, signal processors, and signal splitters for electronic apparatus; measuring and testing machines and instruments, namely, digitizers; laboratory apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; microfluidic testing apparatus not for medical use in the form of assay chips, biological assay chips, and sample processing chips; microfluidic systems, namely, sample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubes, reservoirs, pumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidics, not for medical use used to diagnose cancer; chips, namely, integrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chips, namely, microchips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatus, instruments and devices, namely, calculating machines, central processing units and computers for the input, output, transmission, storage, and processing of data, in particular scientific and medical data relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencingACTIVE—
010[ Medical apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing using fluid technology; diagnostic apparatus for medical use; microfluidic testing apparatus for medical use for testing biomarker expression levels in cell and tissue samples ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 26, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 26, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Feb 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 29, 2025ES71TEAS SECTION 71 RECEIVED—
Oct 29, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 10, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 6, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 6, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 6, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 6, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 27, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 16, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 29, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 29, 2019FIMPFINAL DISPOSITION PROCESSED—
Nov 28, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Oct 29, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 13, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 24, 2019NPUBNOTICE OF PUBLICATION—
Jul 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 6, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 2, 2019DOCKASSIGNED TO EXAMINER—
Jul 2, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 29, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 20, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance